Lipid Management in Clinical Practice (MK-0524A-115)

The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lipid Metabolism Disorder Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients are 18 years of age or older with lipid disorder treated with nicotinic acid/laropiprant

Exclusion criteria

Patient is currently participating in a clinical trial

Treatment and study plan

Primary outcomes

Number of Participants With Lipid Panel Control

Time frame: From Visit 1 entrance evaluation (Week 0) to Visit 2 (between Weeks 8-22)

Lipid Panel Control was defined as achieving target for one or more of the following parameters: low-density lipoprotein cholesterol (LDL-C) at goal (<100mg/dL), high-density lipoprotein cholesterol (HDL-C) within normal range (40mg/dL for males and 50mg/dL for females), and/or triglycerides within normal range (≤ 150mg/dL).

Secondary outcomes

Number of Participants Who Reported Adverse Events

Time frame: Up to 22 weeks

Sponsors and collaborators

Lead sponsor

Merck Sharp & Dohme LLC

Industry

Registry information

Official study title

Lipid Management in Clinical Practice

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Feb 19, 2010
Registry last updated: Aug 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed